sST2 as a screening index for OF patients
Published data show that sST2 was found to independently predict all-cause mortality and heart failure hospitalization in patients with chronic heart failure. In this study, we also found in OF patients the serum expression of sST2 was obviously higher than NC (107.4±5.791ng/mL vs 8.567±0.3466ng/mL, P<0.001) (Figure 2). It means that sST2 can be used as an key screening index for OF patients.